Eupraxia Pharmaceuticals (EPRX) Profit After Tax (2023 - 2026)
Eupraxia Pharmaceuticals (EPRX) posted Profit After Tax of -$14.43 million for the quarter ended Jun 30, 2026, compared with -$8.74 million a year earlier.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Profit After Tax (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Profit After Tax at Eupraxia Pharmaceuticals was -$50.14 million; for the year ended Dec 31, 2025, it was -$38.57 million.
- In prior years, Eupraxia Pharmaceuticals' Profit After Tax was -$25.74 million in the year ended Dec 31, 2024, -$28.89 million in the year ended Dec 31, 2023 and -$18.99 million in the year ended Dec 31, 2022.
- Quarterly Profit After Tax has run from a low of -$16.71 million in the quarter ended Dec 31, 2025 to a high of -$3.96 million in the quarter ended Mar 31, 2023 over five years.
- According to Business Quant data, Profit After Tax for the three prior quarters was -$12.63 million (quarter ended Mar 31, 2026), -$16.71 million (quarter ended Dec 31, 2025) and -$6.37 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -246.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Eupraxia Pharmaceuticals | 363.60 Mn | 362.00 Mn | - | -14.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -14.43 Mn |
| Mar 31, 2026 | -12.63 Mn |
| Dec 31, 2025 | -16.71 Mn |
| Sep 30, 2025 | -6.37 Mn |
| Jun 30, 2025 | -8.74 Mn |
| Mar 31, 2025 | -6.76 Mn |
| Dec 31, 2024 | -7.53 Mn |
| Sep 30, 2024 | -5.99 Mn |
| Jun 30, 2024 | -6.07 Mn |
| Mar 31, 2024 | -6.15 Mn |
| Jun 30, 2023 | -9.51 Mn |
| Mar 31, 2023 | -3.96 Mn |
API Access
Eupraxia Pharmaceuticals Profit After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();